Of late, the tumor microenvironment (TME), which provides a favorable niche for the growth of tumor cells, and epigenetic modifiers that regulate gene expression have garnered significant attention as key drivers of PI3K/AKT activation in OSCC [1,5]. Here, AKT1 is linked to neoplasm.